XML 31 R20.htm IDEA: XBRL DOCUMENT v3.19.1
RESEARCH AND LICENSE AGREEMENT (Details Textual)
3 Months Ended
Mar. 31, 2019
Research And License Agreement [Line Items]  
Percentage Of Royalty Payment If Licensed Product Covered By Valid Claim Or Orphan Drug Status 5.00%
Percentage Of Royalty Payment If Licensed Product Not Covered By Valid Claim Or Orphan Drug Status 3.00%
Validity Of Royalty Payment Not Covered By Valid Claim Or Orphan Drug Status 0 years